TCL Archive ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards? By Cancer History Project November 8, 2002
TCL Archive ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment By Cancer History Project September 27, 2002
TCL Archive Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds. By Cancer History Project December 14, 2001
TCL Archive With Fighter Planes Overhead, ODAC Kept Deliberating. By Cancer History Project September 21, 2001
TCL Archive FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC. By Cancer History Project May 4, 2001
TCL Archive FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC. By Cancer History Project March 30, 2001
TCL Archive ODAC Recommends Femara Campath For FDA Approval. By Cancer History Project January 5, 2001
TCL Archive Cvitkovic Responds To Story On March ODAC Meeting. By Cancer History Project June 23, 2000
ArticleSpotlight Article A Vote for Cancer: Tobacco Advertising and Presidential Elections By The Center for the Study of Tobacco and Society